Roflumilast: first phosphodiesterase 4 inhibitor approved for treatment of COPD

Lignende værker

• Roflumilast, a Novel Phosphodiesterase 4 Inhibitor, for COPD Patients with a History of Exacerbations
  af: Field, Stephen K.
  Udgivet: (2011)
• Roflumilast, a phosphodiesterase-4 inhibitor, induces phagocytic activity in Greek COPD patients
  af: Porpodis K, et al.
  Udgivet: (2015-06-01)
• Roflumilast, a phosphodiesterase-4 inhibitor, induces phagocytic activity in Greek COPD patients
  af: Porpodis, Konstantinos, et al.
  Udgivet: (2015)
• Update on roflumilast, a phosphodiesterase 4 inhibitor for the treatment of chronic obstructive pulmonary disease
  af: Rabe, Klaus F
  Udgivet: (2011)
• PDE4 inhibitors as potential therapeutic agents in the treatment of COPD-focus on roflumilast
  af: Boswell-Smith, Victoria, et al.
  Udgivet: (2007)